A ligament is a band of tissue that holds the bones together, keeping the knee stable. Primarily these ligaments are broadly classified into cruciate ligament and collateral ligament. Further, these are divided into four primary ligaments, namely, Anterior Cruciate Ligament (ACL), Posterior Cruciate Ligament (PCL), Medial Collateral Ligament (MCL), and Lateral Collateral Ligament (LCL). The cruciate ligaments, i.e., the PCL and ACL are crossed ligaments that stabilize the joint while allowing a very large range of motion. Knee injuries are usually the most common musculoskeletal traumas among people, where the Anterior Cruciate Ligament (ACL) injury is one of the utmost frequent occurring knee injuries. Surgical reconstruction is the standard gold treatment for treating knee injuries. Increasing incidences of sports-related injuries have become a leading cause of soft tissue injuries worldwide. Athletes are most likely to injure the ACLs disabling complete stretching of their legs. A type of surgery that involves reconstruction of the ligament is known as ACL reconstruction that lies in the center of one’s knee with a graft.
The Americas dominates the cruciate ligament diagnosis and treatment market owing to the rising prevalence of osteoarthritis among the elderly population, well-developed surgical technology, high healthcare expenditure, and the presence of the leading players.

Market Analysis and Insights: Global Cruciate Ligament Diagnosis and Treatment Market
The global Cruciate Ligament Diagnosis and Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cruciate Ligament Diagnosis and Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cruciate Ligament Diagnosis and Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cruciate Ligament Diagnosis and Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cruciate Ligament Diagnosis and Treatment market.

Global Cruciate Ligament Diagnosis and Treatment Scope and Market Size
Cruciate Ligament Diagnosis and Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cruciate Ligament Diagnosis and Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Posterior Cruciate Ligament (PCL)
Anterior Cruciate Ligament (ACL)

Segment by Application
Hospitals
Orthopedic Clinics
Ambulatory Surgical Center (ASC)
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Stryker
Arthrex
Zimmer Biomet
DePuy Synthes
Conmed
Smith & Nephew
3M
DJO Global
Breg
Bauerfeind AG
DeRoyal Industries
BSN Medical GmbH